Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients.

	Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients.
	Wang, Rong ; Ye, Weiwu ; Chen, Zhanhong ; Shao, Xiying ; Cao, Wenming ; Wang, Xiaojia ; Zheng, Yabing
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2022-06-01
卷号	40
ISSN号	0732-183X
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000863680304539
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129917]
专题	中国科学院合肥物质科学研究院
作者单位	1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Breast Canc Ctr, Canc Hosp, Hangzhou, Zhejiang, Peoples R China 2.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Breast Med Oncol, Canc Hosp, Hangzhou, Peoples R China 4.Zhejiang Canc Hosp, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Wang, Rong,Ye, Weiwu,Chen, Zhanhong,et al. Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA	Wang, Rong.,Ye, Weiwu.,Chen, Zhanhong.,Shao, Xiying.,Cao, Wenming.,...&Zheng, Yabing.(2022).Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA	Wang, Rong,et al."Identified potential pathogenic variants of BARD1 in 1449 Chinese high-risk breast cancer patients.".JOURNAL OF CLINICAL ONCOLOGY 40(2022).